211 – 220 of 526
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Comparing the Clinical Utility and Diagnostic Performance of Cerebrospinal Fluid P-Tau181, P-Tau217 and P-Tau231 Assays
(
- Contribution to journal › Article
-
Mark
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
(
- Contribution to journal › Article
-
Mark
Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations
(
- Contribution to journal › Article
- 2020
-
Mark
Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration : A translatable marker of synaptic degeneration
(
- Contribution to journal › Article
-
Mark
Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies
(
- Contribution to journal › Article
-
Mark
Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
The implications of different approaches to define AT(N) in Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Relationship between cortical iron and tau aggregation in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Image reconstruction methods affect software-aided assessment of pathologies of [18F]flutemetamol and [18F]FDG brain-PET examinations in patients with neurodegenerative diseases
(
- Contribution to journal › Article